Cargando…
Is There a Space-Based Technology Solution to Problems with Preclinical Drug Toxicity Testing?
Even the finest state-of-the art preclinical drug testing, usually in primary hepatocytes, remains an imperfect science. Drugs continue to be withdrawn from the market due to unforeseen toxicity, side effects, and drug interactions. The space program may be able to provide a lifeline. Best known for...
Autores principales: | Hammond, Timothy, Allen, Patricia, Birdsall, Holly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891399/ https://www.ncbi.nlm.nih.gov/pubmed/27183841 http://dx.doi.org/10.1007/s11095-016-1942-0 |
Ejemplares similares
-
Effects of Space Flight on Mouse Liver versus Kidney: Gene Pathway Analyses
por: Hammond, Timothy G., et al.
Publicado: (2018) -
Preclinical Pharmacokinetic Considerations for the Development of Antibody Drug Conjugates
por: Kamath, Amrita V., et al.
Publicado: (2014) -
Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development
por: Shah, Mihir, et al.
Publicado: (2019) -
PET Imaging in Preclinical Anti-Aβ Drug Development
por: Syvänen, Stina, et al.
Publicado: (2022) -
Using the Lessons Learned From the Clinic to Improve the Preclinical Development of Antibody Drug Conjugates
por: Jackson, Dowdy, et al.
Publicado: (2014)